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Abstract
Background: Magnetic resonance imaging (MRI) has been incorporated as an adjunct to CT to take advantage of
its excellent soft tissue contrast for contouring. MR-only treatment planning approaches have been developed to
avoid errors introduced during the MR-CT registration process. The purpose of this study is to evaluate calculated
dose distributions after incorporating a novel synthetic CT (synCT) derived from magnetic resonance simulation
images into prostate cancer treatment planning and to compare dose distributions calculated using three previously
published MR-only treatment planning methodologies.
Methods: An IRB-approved retrospective study evaluated 15 prostate cancer patients that underwent IMRT (n = 11) or
arc therapy (n = 4) to a total dose of 70.2-79.2 Gy. Original treatment plans were derived from CT simulation images
(CT-SIM). T1-weighted, T2-weighted, and balanced turbo field echo images were acquired on a 1.0 T high field open
MR simulator with patients immobilized in treatment position. Four MR-derived images were studied: bulk density
assignment (10 HU) to water (MRW), bulk density assignments to water and bone with pelvic bone values derived
either from literature (491 HU, MRW+B491) or from CT-SIM population average bone values (300 HU, MRW+B300), and
synCTs. Plans were recalculated using fixed monitor units, plan dosimetry was evaluated, and local dose differences
were characterized using gamma analysis (1 %/1 mm dose difference/distance to agreement).
Results: While synCT provided closest agreement to CT-SIM for D95, D99, and mean dose (<0.7 Gy (1 %)) compared to
MRW, MRW+B491, and MRW+B300, pairwise comparisons showed differences were not significant (p < 0.05). Significant
improvements were observed for synCT in the bladder, but not for rectum or penile bulb. SynCT gamma analysis pass
rates (97.2 %) evaluated at 1 %/1 mm exceeded those from MRW (94.7 %), MRW+B300 (94.0 %), or MRW+B491 (90.4 %). One
subject’s synCT gamma (1 %/1 mm) results (89.9 %) were lower than MRW (98.7 %) and MRW+B300 (96.7 %) due to
increased rectal gas during MR-simulation that did not affect bulk density assignment-based calculations but was
reflected in higher rectal doses for synCT.
Conclusions: SynCT values provided closest dosimetric and gamma analysis agreement to CT-SIM compared to bulk
density assignment-based CT surrogates. SynCTs may provide additional clinical value in treatment sites with greater
air-to-soft tissue ratio.
Keywords: MR simulation, Synthetic CT, Radiotherapy treatment planning, Radiation oncology
* Correspondence: jkim8@hfhs.org
Department of Radiation Oncology, Henry Ford Health System, 2799 W.
Grand Blvd, Detroit, MI 48202, USA
© 2015 Kim et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kim et al. Radiation Oncology  (2015) 10:239 
DOI 10.1186/s13014-015-0549-7
Background
Radiation therapy treatment planning was developed
using computed tomography (CT) as its base imaging mo-
dality due to accurate geometric fidelity and the straight-
forward conversion from linear attenuation coefficients to
electron density values. However, a major drawback in CT
is its poor soft tissue contrast that makes it difficult to
accurately identify and contour soft tissue structures. Con-
versely, magnetic resonance imaging (MRI) provides ex-
cellent soft tissue contrast. Thus, efforts have been made
to incorporate MRI into the treatment planning process.
MR images would first be registered to the CT simulation
image (CT-SIM), and MR-contoured structures would
then be transferred onto the CT-SIM for treatment plan-
ning. Unfortunately, the registration process introduces
additional systematic uncertainties (~1-2 mm for pelvis)
[1] that would propagate throughout the treatment plan-
ning workflow. Moreover, having two simulation modal-
ities can be cost-prohibitive while introducing additional
burden on the clinical workflow. Therefore, interest has
grown in developing an MR-only workflow for radiother-
apy treatment planning [2, 3].
While the benefits of MR imaging (i.e. excellent soft
tissue contrast and lack of ionizing radiation) are sub-
stantial, several logistical difficulties must be overcome
before MR-only simulation for radiotherapy would be
practical clinically. The first major issue is geometric dis-
tortion, which is typically categorized as either machine-
specific or patient-specific. The main machine-specific
sources of distortion are inhomogeneity of the main
magnetic field and non-linearity in the magnetic field
produced by gradient coils, while magnetic susceptibility-
induced distortion is the dominant form of patient-specific
errors. Many papers have been published characterizing
the magnitude of these distortions and the post-processing
of the image needed to correct for them [4]. Through vari-
ous correction schemes and the use of MR sequences such
as 3D turbo spin echo sequences, it has been reported that
distortions can be reduced to within acceptable tolerance
for radiotherapy purposes for many treatment sites [3].
Another significant limitation of MRI is that there is
no fundamental relationship between MRI image inten-
sity values and the electron density information required
by treatment planning systems to accurately account for
heterogeneity within a patient for accurate dose calcula-
tion. The most straightforward method to overcome this
obstacle is to assume no significant heterogeneities exist
and assign a bulk electron density value equivalent to
water within the entire body contour [5, 6]. However,
this approach introduces uncertainties in the prostate of
up to 2.5 % [5]. Variations of this method have been in-
troduced where one or more structures that introduce
large heterogeneities (e.g. bone or air) are segmented
and assigned appropriate relative electron density values
[3, 6, 7], which reduced the dose uncertainty to less than
1.5 %. Other methods that have been introduced are
based on the use of atlases [8] or statistical models [9, 10].
Atlas-based methods may struggle with atypical anatomy,
such as cases with local recurrence after radical prostatec-
tomy. Presently, studies incorporating statistical methods
have focused mainly in the brain region and rely on se-
quences that may have difficulty with larger field of view
(FOV) body sites such as the pelvis.
We recently introduced a novel, voxel-based, weighted-
summation method for generating synthetic CTs (synCTs)
from MRI images for male pelvis anatomy [11]. While
preliminary dosimetric comparisons were made between
synCT and CT-SIM, we build on our initial investigation
by evaluating synCT performance relative to three other
established approaches for MR-only treatment planning of
prostate cancer. In this paper, the use of synCT for dose
calculation was compared to the use of bulk density as-
signment methods in order to elucidate situations where
implementation of the synCT algorithm may be beneficial.
Methods
Patients
Retrospective analysis was performed for 15 early stage
(T1 or T2, N0, M0) prostate cancer patients with a me-
dian patient age of 71 years (range: 53–96) that were en-
rolled in an institutional review board-approved study
wherein MR-simulation was performed as an adjunct to
the CT-simulation process. The planning target volume
(PTV) was composed of the prostate and proximal sem-
inal vesicles for 13 patients, while the two remaining pa-
tients were treated for local recurrence in the prostate/
seminal vesicle bed after radical prostatectomy. All pa-
tients underwent radiotherapy delivered using either
intensity-modulated radiation therapy (IMRT, n = 11) or
volume-modulated arc therapy (VMAT, n = 4) to a total
dose of 70.2-79.2 Gy. All patients received the same
preparation instructions for both imaging sessions: full
bladder and empty rectum, which is consistent with our
clinical practice [12].
CT acquisition
A Brilliance Big Bore (Philips Health Care, Cleveland, OH)
CT scanner was used to acquire pelvis images using the
following parameters: 140 kVp, 500 mAs, 512x512 in-
plane image dimensions, 1.28x1.28 mm2 in-plane spatial
resolution, and 3 mm slice thickness.
MR acquisition
A 1.0 T Panorama High Field Open (Philips Medical
Systems, Best, Netherlands) MR simulator was used with
rigid, solenoid-based body coils and a flat tabletop insert
(Civco, Orange City, IA). Patients were aligned and
leveled to their tattoos from CT simulation, and the
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same immobilization devices (banded feet and shaped
foam pad for legs) were used. T1-weighted fast field echo,
T2-weighted turbo spin echo, and balanced turbo field
echo images were acquired for each patient.
Sequences were collected using the parameters for
repetition time (TR), echo time (TE), flip angle (α), FOV,
and image resolution provided in Table 1. Total scan
time to collect these sequences was approximately
18 min. An inverse T1 image was also generated by sub-
tracting the T1 image from the intensity value below
which fell 95 % of the area under the curve of the inten-
sity value histogram for the T1 image. Inverse T1 images
provided high intensity values in bone regions for the
synCT algorithm.
CT surrogate generation
Four different established approaches of defining MR-
derived CT surrogates were generated for comparison
with the CT-SIM. The first was a homogeneous electron
density relative to water assignment of 1.0 to the entire
external contour (MRW) [3]. The second approach, de-
fined as MR (water + bone = 491 HU or MRW+B491) in-
cluded two segments: relative density assignment of 1.0
for the external contour and relative electron density as-
signment of 1.27 [13] (equivalent to 491 HU) to bone
that was manually contoured on the T2-weighted MR
image. While assigning 491 HU to bone has been used
in the literature, it has been observed that this value
may be too high for the femoral heads [14] since the
higher proportion of cancellous (i.e. spongy) bone within
the femoral head would reduce its relative electron dens-
ity. Consequently, it has been found that calculating the
average CT value within the femoral heads for the patient
population provides more accurate relative electron density
values that produce dose distributions closer to original
CT-based treatment plans [14]. We followed this workflow
by contouring the femoral heads for each patient and calcu-
lating the average CT value over the full set of 15 patients,
which yielded a value of ~300 HU. Therefore, the third
approach included a relative density assignment of 1.0 to
the external contour as well as an assignment of 300 HU
(relative electron density ≈ 1.14) to the femoral heads
(water + bone = 300 HU or MRW+B300). The final approach
was to generate synCTs via the method described in detail
in a previous publication [11]. Briefly, manual segmentation
of bone was followed by automatic segmentation of four
other predetermined classes (air, soft tissue, fat, and fluid)
using k-means clustering and morphological operations.
Each synCT voxel value was then calculated as a summa-
tion of intensity values from the acquired MR images that
had been weighted by sequence- and class-specific factors.
The various MR-derived surrogates are shown in Fig. 1.
Treatment planning
All patients were treated using CT-SIM based plans
created in the Eclipse® treatment planning system (Varian
Medical Systems, Palo Alto, CA) with physician-contoured
target and organ-at-risk (OAR) volumes. Treatments were
delivered using either IMRT with seven or nine fields deliv-
ering 1.8-2.0 Gy/fraction (dose range: 75.6-79.2 Gy) or
VMAT using a single arc to deliver 1.8-2.0 Gy/fraction
(dose range: 70–78 Gy). Once generated, each CT surro-
gate was interpolated onto the original CT-SIM image grid
and imported into Eclipse®. The synCT was rigidly regis-
tered to the CT-SIM image, and all other CT surrogates
were registered by applying those same transformation
coordinates derived from the registration of the synCT
image. Original CT-SIM treatment plans were copied onto
each CT surrogate, and dose was recalculated using ori-
ginal plan parameters. Target and OAR contours were then
transferred from the CT-SIM to each CT surrogate for
analysis.
Standard dose-volume histogram (DVH) metrics were
evaluated for the target and OARs. PTVs were compared
using D99, D95, and mean dose to prostate where Dx is
equal to the dose delivered to x% of the structure volume.
Bladders, prostates, and penile bulbs were analyzed using
dosimetric indices defined in QUANTEC guidelines
[15–17]. Namely, D15, D25, and D35 were calculated
for the bladder [15] with observed clinical symptoms as
an endpoint. D15, D25, and D35 were calculated for
the rectum based on their use in evaluating the risk for
late rectal toxicity [16]. Finally, D90 for the penile bulb,
which is used to assess the risk of radiotherapy-induced
erectile dysfunction [17], was calculated. Absolute dif-
ferences between dosimetric values calculated using
CT-SIM, taken as ground truth, and those calculated
using each of the MR-derived CT surrogates were
determined. Relative agreement with CT-SIM-derived
dose values was evaluated through a paired comparison
between each set of pseudo-CT images using nonpara-
metric signed rank tests with the significance level set
Table 1 MR sequence parameters
Acquisition Reconstruction
TR (ms) TE (ms) α (°) FOV (mm3) Voxel size (mm3) Grid size Voxel size (mm3)
T1 Fast field echo ~17 6.9 25 300x400x250 1.50x1.50x2.5 640x640x250 or 576x576x250 0.65x0.65x2.5
T2 Turbo Spin Echo ~5500 80 90 300x400x250 1.00x1.14x2.5 640x640x250 or 576x576x250 0.65x0.65x2.5
bTFE 5.4 2.7 75 300x400x250 1.50x1.50x2.5 672x672x250 or 432x432x250 0.65x0.65x2.5
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to p = 0.05. Moreover, 2D gamma analysis (evaluated at
1 %/1 mm and 2 %/2 mm dose difference/distance to
agreement) was performed to compare axial dose distri-
butions at isocenter for each of the MR-derived treat-
ment plans to those from the CT-SIM-based plans.
Results
Dosimetric criteria
Table 2 compares the population average values along
with standard deviation and 95 % confidence intervals
for selected DVH metrics calculated using CT-SIM-
based treatment plans with those of each CT surrogate-
based plans. While synCT yielded the smallest dosi-
metric differences from CT-SIM for target D95, D99,
and mean dose (<0.7 Gy (1 %)) compared to MRW,
MRW+B491, and MRW+B300, pairwise comparisons showed
that dose reduction was only statistically significant
relative to MRW+B491. Figure 2 shows that the synCT
tended to have closer agreement overall with CT-SIM
values, but that patient-specific results were variable. In
addition, using population average values for bone assign-
ment (i.e. MRW+B300) provided significant improvements
relative to MRW+B491 for all metrics. For bladder, SynCT-
derived dose values displayed closest average agree-
ment with CT-SIM dose values for all metrics, with
small (<1 %) but significant improvements relative to
MRW, MRW+B491, and MRW+B300. For the rectum and
penile bulb, all MR-derived images showed good agree-
ment (difference <1 %) with original CT-SIM calculated
values, and no significant differences were observed be-
tween synCT, MRW, and MRW+B300. MRW+B491 performed
significantly worse for all metrics. Figure 3 displays
DVHs for Patient 5, whose OAR results showed aver-
age agreement with CT-SIM values, and Patient 8,
Table 2 Average and standard deviation results for select target and OAR DVH metrics with 95 % confidence intervals in
parentheses
CT-SIM MRW MRW+B491 MRW+B300 synCT
PTV
D95 (Gy) 74.9 ± 3.5 (72.9, 76.8) 75.2 ± 3.9 (73.2, 77.2) 73.5 ± 3.7 (71.5, 75.6) 74.2 ± 3.8 (72.1, 76.3) 75.1 ± 3.7 (73.2, 77.0)
D99 (Gy) 73.1 ± 3.8 (71.0, 75.2) 73.5 ± 4.1 (71.4, 75.6) 71.8 ± 4.2 (69.4, 74.1) 72.5 ± 4.2 (70.1, 74.8) 73.3 ± 3.8 (71.2, 75.4)
Mean Dose (Gy) 76.8 ± 3.4 (74.9, 78.7) 77.1 ± 3.8 (75.2, 79.1) 75.5 ± 3.6 (73.6, 77.5) 76.2 ± 3.7 (74.2, 78.3) 77.2 ± 3.6 (75.2, 79.2)
Bladder
D15 (Gy) 65.0 ± 10.4 (59.3, 70.8) 64.9 ± 10.2 (59.3, 70.6) 63.5 ± 10.6 (57.6, 69.4) 64.0 ± 10.8 (58.0, 70.0) 65.0 ± 10.6 (59.1, 70.9)
D25 (Gy) 51.1 ± 10.5 (45.2, 56.9) 50.8 ± 10.4 (45.0, 56.5) 50.0 ± 10.7 (44.0, 55.8) 50.2 ± 10.9 (44.1, 56.2) 51.0 ± 10.5 (45.1, 56.8)
D35 (Gy) 39.1 ± 10.9 (33.1, 45.2) 38.8 ± 10.8 (32.9, 44.8) 38.4 ± 10.8 (32.5, 44.4) 38.6 ± 10.9 (32.5, 44.6) 39.0 ± 10.9 (33.0, 45.1)
Rectum
D15 (Gy) 64.0 ± 6.0 (60.6, 67.3) 64.2 ± 6.3 (61.0, 67.4) 63.1 ± 6.1 (60.0, 66.1) 63.6 ± 6.2 (60.4, 66.7) 64.3 ± 6.3 (61.0, 68.0)
D25 (Gy) 55.4 ± 6.9 (51.6, 59.2) 55.5 ± 7.0 (51.9, 59.0) 54.7 ± 6.8 (51.3, 58.2) 55.1 ± 6.9 (51.6, 58.6) 55.8 ± 6.8 (52.0, 59.8)
D35 (Gy) 48.8 ± 7.4 (44.7, 52.9) 48.9 ± 7.4 (45.2, 52.6) 48.3 ± 7.3 (44.6, 52.0) 48.6 ± 7.3 (44.9, 52.3) 49.2 ± 7.5 (45.4, 53.0)
Penile Bulb
D90 (Gy) 13.9 ± 16.9 (4.2, 23.6) 14.9 ± 17.0 (4.9, 24.5) 14.6 ± 16.8 (5.1, 24.7) 14.7 ± 16.9 (5.1, 24.8) 14.8 ± 17.2 (4.7, 24.8)
Fig. 1 CT and MR-derived CT surrogate images. (Top) Patient CT and T2-weighted MR images. (Bottom) MR-derived CT surrogates used for study:
synthetic CT (synCT), T2 with water bulk density assignment (MRW), T2 with bulk density assignments of water and bone (MRW+B)
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who displayed the largest deviation from those values
(up to 3 %, 2 %, and 3.5 % for bladder, rectum, and
penile bulb, respectively). For Patient 8, the bulk density
assignment-based approaches produced dose values
lower than those produced for CT-SIM because of a
higher than normal amount of fatty tissue, where CT-
SIM values were lower than bulk assigned HU values.
Conversely, while synCT tissue HU values were fairly
close to those in CT-SIM, synCT bone HU values tended
to be lower for this patient, leading to higher calculated
dose values.
Gamma analysis
Overall, synCT gamma analysis pass rates at 1 %/1 mm
(97.2 %) exceeded those for MRW (94.7 %), MRW+B491
(90.4 %), and MRW+B300 (94.0 %) with individual patient
results at both 2 %/2 mm and 1 %/1 mm for each CT
surrogate shown in Table 3. Generally, gamma analysis
conducted at 2 %/2 mm was not sensitive enough to
reveal significant differences between CT surrogates
(pass rates ranging from 97.8 % (MRW+B491) to 99.8 %
(synCT)). Figure 4 displays a typical gamma analysis case
where the synCT showed slightly better agreement than
alternative CT surrogate methods. One exception to this
trend occurred for Patient 11, whose gamma analysis
results at 1 %/1 mm were lower for synCT (89.9 %) than
for MRW (98.7 %) or MRW+B300 (96.7 %). As Fig. 5a
illustrates, there was a large increase in rectal gas during
MR simulation relative to that present during CT simu-
lation. While this did not affect the bulk density assign-
ment methodologies tested, Fig. 5 shows that the change
in air volume was propagated to the generated synCT
(Fig. 5e). The increased air volume led to higher calcu-
lated doses for the synCT-derived treatment plan while
the bulk density assignment-based methods remained
unaffected (Fig. 5g). For this case, synCT rectal doses
Fig. 2 Percent difference in D95 to PTV. Percent difference in D95 to PTV between CT-based dose calculations and dose calculations derived from
each CT surrogate for each patient
Fig. 3 Patient dosimetric results. a Average and b worst case patient DVHs. Good agreement is observed for all treatment plans. SynCT provided
closest agreement to CT-SIM results for PTV and bladder, while no significant differences were observed for rectum and penile bulb
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Table 3 Patient gamma analysis results for both 2 %/2 mm and 1 %/1 mm dose difference/distance to agreement
MRW MRW+B491 MRW+B300 synCT
2 %/2 mm 1 %/1 mm 2 %/2 mm 1 %/1 mm 2 %/2 mm 1 %/1 mm 2 %/2 mm 1 %/1 mm
Patient 1 1.00 0.96 1.00 0.95 1.00 0.99 1.00 0.98
Patient 2 1.00 0.96 1.00 0.97 1.00 1.00 1.00 1.00
Patient 3 0.97 0.90 1.00 0.99 1.00 0.98 1.00 0.99
Patient 4 1.00 0.98 0.97 0.91 1.00 0.98 1.00 0.97
Patient 5 1.00 0.99 0.96 0.88 1.00 0.93 1.00 0.99
Patient 6 0.93 0.87 1.00 0.99 1.00 0.94 1.00 0.99
Patient 7 0.96 0.91 1.00 0.99 1.00 0.96 1.00 0.99
Patient 8 0.99 0.94 0.93 0.82 0.98 0.88 0.99 0.95
Patient 9 1.00 0.98 0.96 0.91 0.99 0.94 1.00 0.99
Patient 10 1.00 0.99 0.99 0.93 1.00 0.96 1.00 1.00
Patient 11 1.00 0.82 0.96 0.64 0.99 0.72 1.00 0.90
Patient 12 1.00 0.99 0.99 0.90 1.00 0.97 0.99 0.90
Patient 13 1.00 0.97 1.00 0.92 1.00 1.00 1.00 0.94
Patient 14 1.00 0.97 0.94 0.86 0.98 0.92 1.00 1.00
Patient 15 1.00 0.98 0.98 0.90 1.00 0.94 1.00 0.99
Mean 0.99 0.95 0.98 0.90 1.00 0.94 1.00 0.97
Min 0.93 0.82 0.93 0.64 0.98 0.72 0.99 0.90
Max 1.00 0.99 1.00 0.99 1.00 1.00 1.00 1.00
Fig. 4 Patient gamma analysis results. Dose plans at isocenter derived from a CT-SIM and b synCT and resulting c gamma distribution (pass rate:
99.95 %) evaluated at 1 %/1 mm for a typical patient (Patient 14) treated to 78 Gy. d Line profile through a compares dose differences between
CT-SIM and CT surrogates
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were systematically higher than all other approaches:
MRW by 1.6-2.6 Gy (4.3-5.6 %), MRW+B300 by 1.8-3.0 Gy
(4.6-5.8 %), and MRW+B491 by 2.0-3.5 Gy (5.0-6.2 %).
Discussion
This work sought to incorporate synCTs and previously
published bulk density assignment-based CT surrogates
into the development of radiotherapy treatment plans
and to evaluate the resulting dose distributions in order
to determine the impact of integrating synCT into the
treatment planning workflow. Overall, target and OAR
dose metrics and gamma analysis used for comparison
revealed that synCT-derived treatment plans tended to
provide closer agreement to CT-SIM than bulk density
assignment-based approaches. While 3D gamma analysis
has recently emerged as a tool for evaluating the entire
irradiated volume of both target and OARs, 2D gamma
analysis has been reported to yield more stringent results
[18] and is consistent with our clinical practice. The
most significant OAR differences were observed for
the bladder. Consistent with the literature [14], the
MRW+B491 tended to perform significantly worse than
other MR-derived images due to its high bone relative elec-
tron density values that yielded slight underestimations of
dose to target and OARs relative to the CT-SIM plan. Use
of population average-derived relative electron density
values for MRW+B300 provided better agreement with
original CT-SIM plan dose distributions than MRW+B491.
However, the improvement, though statistically significant,
was minimal (~0.5 %), which is consistent with previous
reports (~0.6 %) [14].
Common external contours were used that may
mask dosimetric differences between dose distributions
calculated using CT-SIM and those using MR-derived
CT substitutes due to changes in treatment beam path
length. These were added to correct for changes in
patient geometry between different patient setups, par-
ticularly for cases having a time lapse of up to two
weeks between CT and MR simulation. This effect
was assumed to be small. Consistent with that as-
sumption, the number of added voxels amounted to
<5 % of the whole, and these were mainly concen-
trated around the abdomen and out of the path of the
treatment beams.
Fig. 5 Case study. Visible increase in rectal air volume during MR simulation relative to CT simulation for Patient 11 seen when comparing a
T2-weighted MR image, b CT-SIM, and c synCT. Resulting differences in dose distributions at isocenter from d CT-SIM were seen in e dose
distributions from synCT but not from methods assigning bulk electron density values to f water, h water + bone (491 HU), and i water + bone
(300 HU). Increased dose for synCT can be seen in g vertical line profiles taken through dose planes at isocenter
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With the exception of MRW, which does not take into ac-
count tissue heterogeneities, all CT replacement methods
that were evaluated required manual segmentation of bone.
Manual bone segmentation is time-consuming, making its
clinical implementation impractical. Currently, different av-
enues for automatically segmenting bone in MR images of
the prostate are under investigation. Both atlas-based [8]
and statistical model-based approaches [9, 10] have been
proposed. In atlas-based methods, probabilistic methods
are employed to automatically segment structures of
interest. Atlas-based methods rely on the accuracy of
the implemented multimodal deformable image regis-
tration algorithm and, therefore, appear to be prone
to the same MR-CT registration errors that implementa-
tion of an MR-only treatment planning workflow attempts
to avoid. Statistical methods utilize magnitude information
from several MR sequences to identify clusters associated
with different segment types in the joint histogram and to
determine the probability that a voxel belongs to each of
the clusters. Like air, bone appears as a signal void in con-
ventional MR images because of its low proton density
and extremely short T2 signal lifetime [19]. Therefore,
bone tends to be segmented with air. While ultrashort
echo time (UTE) sequences may help to obtain a discern-
ible signal from bone in order to separate bone from air,
UTE has mainly been focused on the head region because
of difficulties in attaining acceptable image quality at
larger FOVs.
While reducing the time required for image post-
processing and synCT generation is important, it is also
important to reduce the scan time for the patient. The
stated time to acquire the requisite images for our
synCT workflow is ~18 min for a 1.0 T scanner. By con-
trast, a CT-SIM scan can be obtained in <1 min. Long
scan times may cause degradation of image quality due
to patient motion or variation in patient internal anat-
omy (e.g. changes in bladder and rectal filling). Scan
times would be reduced at higher field strengths where
increases in signal-to-noise ratio would also enable more
aggressive acceleration factors, thereby reducing acquisition
time. Future work will explore reducing the number of
image sets needed to generate synCTs without introducing
significant errors.
Variation in the level of rectal and bladder filling has
been shown to deform the shape and to shift the pos-
ition of the prostate and seminal vesicles by as much as
0.7 cm [20], leading to a reduction in local control for
prostate cancer radiotherapy [21]. Therefore, the level of
bladder and rectal filling must be reproducible between
simulation and delivery of treatment. There is an
increased risk that the level of rectal and bladder filling
may change during an MR session simply due to the
extended scan time for MR compared to that of CT. To
mitigate this risk, it was recommended that steps be
taken to ensure the patient has a full bladder [22] and
empty rectum [21] prior to simulation such as regular
patient instruction before and during the course of treat-
ment. In extreme cases, administration of an enema
prior to simulation may be warranted [21].
Results from Patient 11 indicate that synCT may pro-
vide greater value in regions with a higher air-tissue ra-
tio, such as the brain or head and neck where airways
are more prevalent. Manual segmentation in these re-
gions is more difficult and time-intensive than for the
prostate and would only further strain clinical workflow.
For future implementations of the synCT workflow in the
brain to be viable clinically, some method to automatically
and accurately differentiate air from bone would be neces-
sary. A promising method for accurately segmenting air
separately from bone using UTE phase information is cur-
rently under development in our group.
Conclusions
Overall, synCT-based treatment plans provided dosimetric
and gamma analysis values in close agreement to original
CT-based treatments plans consistent with previously
published bulk density assignment-based substitute CT
images, with significant improvement relative to those
other substitute CT images observed for bladder.
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